Optimizing Myocardial Protection in Minimally Invasive Cardiac Surgeries: A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia
Journal of Clinical Medicine · 19.11.2024 · 13 (22) · 6977
DOI: 10.3390/jcm13226977 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.11.2024. Verfasst von Sadeq Al-Hasan-Al-Saegh und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30625 Hannover, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The optimal choice of cardioplegia solution in minimally invasive cardiac surgeries (MICS) remains debated, as prolonged myocardial protection is essential to avoid interruptions to the surgical flow, which can prolong aortic cross-clamp time and cardiopulmonary bypass time, especially in the constrained surgical field. We conducted a network meta-analysis to evaluate the safety and efficacy of the del Nido (DN), histidine-tryptophan-ketoglutarate (HTK), blood cardioplegia (BC), and St. Thomas’ (STH) solutions in MICS.
Methods
Medical electronic databases were thoroughly searched without time restrictions, including all types of studies except for study protocols and animal research. The final search was completed in June 2024. Subsequently, a network meta-regression was performed on both primary and secondary endpoints, utilizing R (The R Foundation for Statistical Computing, version 3.6.2) for the analysis. Meta-analyses were carried out using Review Manager software.
Results
A total of 15 studies, enrolling 2282 patients, were included in the analysis. None of the comparisons showed statistically significant differences in in-hospital mortality between the four cardioplegia solutions (BC vs. HTK, OR: 3.21, 95% CI: 0.13–80.84; DN vs. HTK, OR: 1.42, 95% CI: 0.28–7.23; STH vs. HTK, OR: 1.25, 95% CI: 0.19–8.20).
Conclusions
In this network meta-analysis of cardioplegia solutions in MICS, no significant differences were observed in major clinical outcomes across the solutions. Cardioplegia solutions that provide long-lasting myocardial protection with a single dose, such as DN and HTK, were found to be safely applied in MICS. DN was associated with shorter CPB times and HTK was associated with shorter hospital stays, though these differences may not have clinical implications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, 30625 Hannover, Germany.
- Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
- Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, IRCCS Italian Cardiology Network, 16132 Genova, Italy.
- Department of Cardiac and Thoracic Vascular Surgery, Marburg University Hospital, 35043 Marburg, Germany.
- Department of Cardiovascular Surgery, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, 16310 Bursa, Turkey.
- Department of Cardiology, Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Italy.
ORCID-Profile: Sho Takemoto, Stefano Benenati, Senol Yavuz, Mattia Galli, Florian Helms, Saeed Torabi, Tim Kaufeld, Aron-Frederik Popov, Arjang Ruhparwar
Zitieren
APA
Al-Hasan-Al-Saegh, S., Takemoto, S., Benenati, S., Shafiei, S., Yavuz, S., Galli, M., Helms, F., Amanov, L., De Manna, N. D., Torabi, S., Karsten, J., Schmitto, J. D., Ius, F., Kaufeld, T., Salman, J., Popov, A. F., Schmack, B., Ruhparwar, A., Zubarevich, A., & Weymann, A. (2024). Optimizing Myocardial Protection in Minimally Invasive Cardiac Surgeries: A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia. Journal of Clinical Medicine, 13(22), 6977. https://doi.org/10.3390/jcm13226977
Vancouver
Al-Hasan-Al-Saegh S, Takemoto S, Benenati S, Shafiei S, Yavuz S, Galli M, et al. Optimizing Myocardial Protection in Minimally Invasive Cardiac Surgeries: A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia. Journal of Clinical Medicine. 2024;13(22):6977. doi:10.3390/jcm13226977
BibTeX
@article{AlHasanAlSaegh2024,
author = {Al-Hasan-Al-Saegh, Sadeq and Takemoto, Sho and Benenati, Stefano and Shafiei, Saeed and Yavuz, Senol and Galli, Mattia and Helms, Florian and Amanov, Lukman and De Manna, Nunzio Davide and Torabi, Saeed and Karsten, Jan and Schmitto, Jan Dieter and Ius, Fabio and Kaufeld, Tim and Salman, Jawad and Popov, Aron-Frederik and Schmack, Bastian and Ruhparwar, Arjang and Zubarevich, Alina and Weymann, Alexander},
title = {Optimizing Myocardial Protection in Minimally Invasive Cardiac Surgeries: A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {22},
pages = {6977},
doi = {10.3390/jcm13226977}
}
EUVIMED